Sign-in to Ask A Doctor - 24x7
OR
Sign in with GoogleGet your health question answered instantly from our pool of 18000+ doctors from over 80 specialties
Treatment For Deep Venous Thrombosis
What is best treatment for DVT in 11 year old child.........please tell me in detail with medication and injection name
posted on
Mon, 5 Apr 2010
Medically reviewed by
Ask A Doctor - 24x7 Medical Review Team
Mon, 12 Apr 2010
Answered on
Sun, 20 Nov 2011
Last reviewed on
Anonymous's Response
Annonymous's
Response
Oral anticoagulants(Warfarin) are the mainstay of treatment for DVT, taken lifelong if indicated. But treatment is first initiated with an injectable anticoagulant-LMWHeparin for first few weeks.
In children with thrombosis, initial anticoagulant therapy with either unfractionated heparin (UFH) or LMWH (clexane) is recommended for at least 5 to 10 days followed by VKAs (warfarin, acetrom)
Children with idiopathic thromboembolism should receive anticoagulant therapy for at least 6 months, using VKAs to achieve a target INR of 2.5 (INR range, 2.0 to 3.0) or alternatively using LMWH to maintain an anti-FXa level of 0.5 to 1.0 U/mL
Children with secondary thrombosis in whom the risk factor has resolved, anticoagulant therapy be administered for at least 3 months using VKAs to achieve a target INR of 2.5 (INR range, 2.0 to 3.0) or alternatively using LMWH to maintain an anti-FXa level of 0.5 to 1.0 U/mL
Children with recurrent idiopathic thrombosis, should receive indefinite treatment with VKAs to achieve a target INR of 2.5 (INR range, 2.0 to 3.0)
Children with idiopathic thromboembolism should receive anticoagulant therapy for at least 6 months, using VKAs to achieve a target INR of 2.5 (INR range, 2.0 to 3.0) or alternatively using LMWH to maintain an anti-FXa level of 0.5 to 1.0 U/mL
Children with secondary thrombosis in whom the risk factor has resolved, anticoagulant therapy be administered for at least 3 months using VKAs to achieve a target INR of 2.5 (INR range, 2.0 to 3.0) or alternatively using LMWH to maintain an anti-FXa level of 0.5 to 1.0 U/mL
Children with recurrent idiopathic thrombosis, should receive indefinite treatment with VKAs to achieve a target INR of 2.5 (INR range, 2.0 to 3.0)
I find this answer helpful
1 Doctor agrees with this answer
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer.
For a more detailed, immediate answer, try our premium service
[Sample answer]
Related questions you may be interested in
Recent questions on X factor
Loading Online Doctors....